Search research articles
Contact Us
Filters
Showing results (311-320 of 991) with videos related to
Page
of 100
Sort By:
Clinical Pharmacology and Therapeutics
|
June 8, 2017
Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney Disease
O Ai Dhaybi, G L Bakris
Kidney International
|
November 20, 2009
Prehypertension: is it relevant for nephrologists?
Rigas G Kalaitzidis, George L Bakris
Seminars in Nephrology
|
September 18, 2007
Should beta-blockers be used to control hypertension in people with chronic kidney disease?
Peter D Hart, George L Bakris
Journal of Hypertension
|
December 5, 2006
Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents
Pantelis A Sarafidis, George L Bakris
Journal of the American College of Cardiology
|
March 7, 2015
Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3
George L Bakris, Deepak L Bhatt
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 1, 2002
Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options
Domenic A Sica, George L Bakris
Archives of Internal Medicine
|
March 21, 2000
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
G L Bakris, M R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 14, 2018
Blood pressure reduced to new guideline goals in patients with high-normal glucose further reduces cardiovascular events
Omar Al Dhaybi, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 12, 2006
Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?
Panteleimon A Sarafidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 6, 2006
Are beta blockers passé for the treatment of hypertension?
Panteleimon A Sarafidis, George L Bakris
Page
of 100
Search research articles
Search
Showing results (311-320 of 991) with videos related to
Sort By:
Page
of 100
Clinical Pharmacology and Therapeutics
|
June 8, 2017
Renal Targeted Therapies of Antihypertensive and Cardiovascular Drugs for Patients With Stages 3 Through 5d Kidney Disease
O Ai Dhaybi, G L Bakris
Kidney International
|
November 20, 2009
Prehypertension: is it relevant for nephrologists?
Rigas G Kalaitzidis, George L Bakris
Seminars in Nephrology
|
September 18, 2007
Should beta-blockers be used to control hypertension in people with chronic kidney disease?
Peter D Hart, George L Bakris
Journal of Hypertension
|
December 5, 2006
Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents
Pantelis A Sarafidis, George L Bakris
Journal of the American College of Cardiology
|
March 7, 2015
Reply: A mechanistic explanation for the minimal impact of renal denervation on 24-h ambulatory blood pressure in SIMPLICITY HTN-3
George L Bakris, Deepak L Bhatt
Journal of Clinical Hypertension (Greenwich, Conn.)
|
February 1, 2002
Type 2 diabetes: RENAAL and IDNT--the emergence of new treatment options
Domenic A Sica, George L Bakris
Archives of Internal Medicine
|
March 21, 2000
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
G L Bakris, M R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 14, 2018
Blood pressure reduced to new guideline goals in patients with high-normal glucose further reduces cardiovascular events
Omar Al Dhaybi, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 12, 2006
Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?
Panteleimon A Sarafidis, George L Bakris
Journal of Clinical Hypertension (Greenwich, Conn.)
|
April 6, 2006
Are beta blockers passé for the treatment of hypertension?
Panteleimon A Sarafidis, George L Bakris
Page
of 100